Search

Anahid D Jewett

from Valencia, CA
Age ~66
Get Report
Also known as:
Anahid Dr Jewett, Ana Jewett, Arahid Jewett, Jewett Ana
Phone and address:
24913 Knollwood Ln, Santa Clarita, CA 91355
(818) 438-6605
Related to:
Betty B DennDaria JewettDaria J Jewett, 98Keith B Jewett, 64Ann JewettKeith Jewett
Connected to:
Ashley L Jewett, 38Boyd L Jewett, 82Carl J Jewett, 76Cynthia R Jewett, 64Damian D Jewett, 29Doug Jewett, 60Georgia J Jewett, 81Joan E Jewett, 56Joshua R Jewett, 55Leunna Jewett, 55

Anahid Jewett Phones & Addresses

  • 24913 Knollwood Ln, Valencia, CA 91355 (818) 438-6605
  • Santa Clarita, CA
  • 1454 S La Luna Ave, Ojai, CA 93023
  • Hartsel, CO
  • Oxnard, CA
  • Beverly Hills, CA
  • Burbank, CA
  • Glendale, CA
  • 24913 Knollwood Ln, Valencia, CA 91355

Work

Position: Professor and director of tumor immunology

Education

Degree: Associate degree or higher

Emails

k***[email protected]

Industries

Hospital & Health Care

Public records

Vehicle Records

Anahid Jewett

View page
Address:
24913 Knollwood Ln, Valencia, CA 91355
VIN:
WDBUF56X87B084065
Make:
MERCEDES-BENZ
Model:
E-CLASS
Year:
2007

Resumes

Resumes

Anahid Jewett Photo 1

Professor And Director Of Tumor Immunology

View page
Location:
Valencia, CA
Industry:
Hospital & Health Care
Work:

Professor and Director of Tumor Immunology
Ucla Health
Professor and Director of Tumor Immunology Laboratory

Publications

Us Patents

Methods To Prevent Cytotoxicity Using N-Acetyl-Cysteine

View page
US Patent:
8481005, Jul 9, 2013
Filed:
Dec 22, 2010
Appl. No.:
12/976820
Inventors:
Anahid Jewett - Valencia CA, US
Avina Paranjpe - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 8/02
A01N 39/00
A61C 15/00
A61C 5/00
US Classification:
424 50, 424401, 424616, 424 49, 433216, 4332171
Abstract:
Compositions and methods to inhibit adverse physiological effects caused by resin-based and resin-containing materials are disclosed. More specifically, the use of N-acetyl-cysteine (NAC) to inhibit hydroxyethyl methacrylate (HEMA)-mediated cell death and cytotoxicity.

Methods To Prevent Cytotoxicity Using N-Acetyl-Cysteine

View page
US Patent:
20080306158, Dec 11, 2008
Filed:
Jan 2, 2007
Appl. No.:
12/159911
Inventors:
Anahid Jewett - Valencia CA, US
Avina Paranipe - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/195
C07C 229/02
A61P 43/00
US Classification:
514562, 562556
Abstract:
Compositions and methods to inhibit adverse physiological effects caused by resin-based and resin-containing materials are disclosed. More specifically, the use of N-acetyl-cysteine (NAC) to inhibit hydroxyethyl methacrylate (HEMA)-mediated cell death and cytotoxicity.

Osteogenic Enhancer Composition

View page
US Patent:
20090324669, Dec 31, 2009
Filed:
Jul 25, 2007
Appl. No.:
12/374475
Inventors:
Takahiro Ogawa - Torrence CA, US
Anahid Jewett - Valencia CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61F 13/00
A61K 31/195
A61K 31/59
A61K 38/39
A61K 33/42
A61K 31/56
US Classification:
424422, 514562, 514167, 514 12, 424602, 514169
Abstract:
An osteogenic enhancer composition for bone and cartilage repair and methods of using the same are described.

Depletion Of Cancer Stem Cells

View page
US Patent:
20120009203, Jan 12, 2012
Filed:
Jun 29, 2011
Appl. No.:
13/135222
Inventors:
Anahid Jewett - Valencia CA, US
International Classification:
A61K 35/26
A61P 37/06
A61P 35/00
A61K 31/337
A61K 39/395
US Classification:
4241721, 424 937, 514449
Abstract:
Compositions and methods are provided for killing of cancer stem cells, and for the transplantation of pluripotent stem cells and differentiated cells derived therefrom.

Systems And Methods For Evaluating Nk Cells

View page
US Patent:
20220381772, Dec 1, 2022
Filed:
Jul 31, 2020
Appl. No.:
17/629948
Inventors:
- Oakland CA, US
Anahid Jewett - Los Angeles CA, US
International Classification:
G01N 33/50
G01N 33/543
G01N 33/68
Abstract:
The present application relates to natural killer (NK) cell-specific tests that are useful in determining the expansion potential and function of NK cells.

Cannabis Limits Cancer Stem Cell Growth In Poorly Differentiated Cancers

View page
US Patent:
20220331286, Oct 20, 2022
Filed:
Mar 29, 2022
Appl. No.:
17/707134
Inventors:
- Oakland CA, US
Anahid JEWETT - Los Angeles CA, US
International Classification:
A61K 31/352
A61P 35/00
Abstract:
The present invention provides a composition comprising a cannabinoid for inhibiting growth of cancer stem cells. This invention also provides methods of treating cancer comprising cancer stem cells by administering the said composition to patients in need thereof.

Compositions And Methods For Activating Nk Cells

View page
US Patent:
20200306300, Oct 1, 2020
Filed:
Feb 15, 2018
Appl. No.:
16/486123
Inventors:
- Oakland CA, US
Anahid Jewett - Los Angeles CA, US
International Classification:
A61K 35/17
A61K 35/32
A61K 35/741
C12N 5/078
Abstract:
The present application relates to methods of activating a NK cells in vitro, ex vivo, and/or in vivo by an osteoclast cell (OC) and/or a dendritic cell, and methods of treating disease using these activated NK cells.

Oral Composition Comprising Lactic Acid Bacteria For Regulating Immune Responses And Methods Related Thereto

View page
US Patent:
20200009201, Jan 9, 2020
Filed:
Dec 15, 2017
Appl. No.:
16/470040
Inventors:
- Oakland CA, US
Anahid Jewett - Valencia CA, US
International Classification:
A61K 35/744
A61K 35/745
A61K 35/747
A61K 35/32
A61K 45/06
A61K 35/17
A61P 35/00
C12N 5/0783
C12N 5/077
C12N 5/09
A61K 33/243
A61K 31/337
A61K 31/198
Abstract:
The present application relates to probiotic compositions, e.g., comprising at least one bacterial strain selected from: , KE99, and , optionally wherein the at least one bacterial strain is either alive or sonicated.
Control profile
Anahid D Jewett from Valencia, CA, age ~66 Get Report